This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Five Top Chinese Pharma Plays

Editor's note: This is the fifth article in a series on investing in China. The previous columns were Four Ways to Play China, China Investing: Like a Kid in a Toy Store, How (Not) to Invest in China and Catching China's Uplisting Wave.

My grandfather is a berry-picking legend where I come from. The rate at which he picked seems to accelerate as the story propagates, but I would like to show how you can apply successful wild berry-picking principles to stock picking.

Right now, the picking is good in Chinese pharmaceuticals. If you know what you're doing I believe you can turn thousands into millions over the next couple years. And that's after taxes.

1. You need to know where to look.

If you go looking for berries in the desert, you might be disappointed. If you're looking for pharmaceuticals, you might run across Lotus Pharmaceuticals (LTUS.OB). Like Jack's magical beanstalk berry, Lotus is my red pill from the "Matrix" and it's only up 78% since I mentioned it in May.

Although Lotus hasn't taken real steps to uplist and the stock price has had a negative correlation with company performance, it is my belief that not picking up this stock is shortsighted to the highest degree. In June it was again awarded Good Supply Practices certification. If you are shortsighted you'll never make ends meet berry picking and you'll never find a company like Lotus that is growing and trading at less than twice earnings.

2. You need to know when to look.

Although China has been running headlines and a lot of people are bubbling with excitement it was only last year when China was the poison berry. When you buy determines the price you pay and, therefore, the risk you undertake as I believe risk comes only from overpaying.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
CHME $0.01 0.00%
CPHI $0.33 0.00%
AAPL $124.75 0.00%
FB $80.78 0.00%
GOOG $524.05 0.00%


DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs